Paper64654
Immunological and other laboratory studies of patients receiving short-term cimetidine therapy.
McGregor CG and 6 others. Lancet, 1977. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Immunological and other laboratory studies of patients receiving short-term cimetidine therapy. Papers, record 64654. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/64654
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunological and other laboratory studies of patients receiving short-term cimetidine therapy.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Guanidines | Major topic |
| Histamine H2 Antagonists | Major topic |
| Imidazoles | Major topic |
| Administration, Oral | |
| Adult | |
| Alanine Transaminase | |
| Aspartate Aminotransferases | |
| BCG Vaccine | |
| Cell Migration Inhibition | |
| Dysgammaglobulinemia | |
| Female | |
| Humans | |
| Immunity, Cellular | |
| Immunoglobulin A | |
| Leukocytes | |
| Male | |
| Middle Aged | |
| Mycobacterium bovis | |
| Peptic Ulcer | |
| Time Factors |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7249945 | Adverse effects of anti-ulcer drugs. | Drugs | 1981 | https://conductscience.org/library/papers/7249945 | PubMed |
| 6993076 | Cimetidine does not accelerate skin graft rejection in mice. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6993076 | PubMed |
| 6984638 | Immunological studies in patients with alopecia receiving dinitrochlorobenzene and cimetidine therapy. | Arch Dermatol Res | 1982 | https://conductscience.org/library/papers/6984638 | PubMed |
| 6128216 | Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. | Drugs | 1982 | https://conductscience.org/library/papers/6128216 | PubMed |
| 2905759 | Haematological adverse effects of histamine H2-receptor antagonists. | Med Toxicol Adverse Drug Exp | 1988 | https://conductscience.org/library/papers/2905759 | PubMed |
| 2522158 | Immunomodulation of cimetidine in healthy volunteers. | Klin Wochenschr | 1989 | https://conductscience.org/library/papers/2522158 | PubMed |
| 627203 | Role of cimetidine in gastrointestinal disease: present status and future potential. | Drugs | 1978 | https://conductscience.org/library/papers/627203 | PubMed |
| 390894 | Prophylactic gastric operations in uremic patients prior to renal transplantation. | World J Surg | 1979 | https://conductscience.org/library/papers/390894 | PubMed |
| 342231 | Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. | Drugs | 1978 | https://conductscience.org/library/papers/342231 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/64654
GET https://conductscience.org/api/papers/v1/64654/authors